Heparin - Low Molecular Weight Heparin ๐
๐ Low Molecular Weight Heparin (LMWH)
Used for prevention and treatment of thrombosis.
๐ Always consult the BNF or local trust guidelines for exact dosing and monitoring.
๐ฉบ Overview
- ๐งฌ LMWH is derived from unfractionated heparin (UFH) by controlled depolymerisation.
- ๐ Produces a predictable anticoagulant response.
- ๐ฏ Predominantly antiโFactor Xa activity.
- โ๏ธ Allows weight-based dosing without routine lab monitoring in most patients.
- ๐ซ Lower risk of HIT and osteoporosis than UFH.
- ๐ฝ Renally excreted โ dose reduction required in renal impairment.
๐ง Clinical principle: LMWH simplifies anticoagulation, but renal function must always be checked first.
โ๏ธ Mechanism of Action
- ๐ Binds to antithrombin III.
- โ Accelerates inactivation of Factor Xa.
- ๐ Smaller effect on thrombin (Factor IIa) than UFH.
- ๐ Given subcutaneously.
- โ ๏ธ Protamine only partially reverses its effect.
๐ฏ Clinical Indications
- ๐ฉธ Prevention of VTE in medical and surgical patients.
- ๐ Treatment of DVT and PE.
- โค๏ธ Acute coronary syndromes.
- ๐ฅ Bridging therapy around procedures.
- ๐คฐ Anticoagulation in pregnancy (preferred over warfarin).
- ๐ฆ Cancer-associated thrombosis.
๐ซ Contraindications & Cautions
- โ High Bleeding Risk
- Thrombocytopenia, haemophilia.
- Severe liver failure.
- Severe renal impairment.
- Uncontrolled hypertension (>200/120).
- Active GI ulceration.
- Varices, aneurysm, proliferative retinopathy.
- Recent major surgery (brain, spine, eye).
- Recent intracranial haemorrhage.
- โ ๏ธ Heparin-Induced Thrombocytopenia (HIT)
- Previous HIT = absolute contraindication.
- Use alternative anticoagulant.
๐ Monitoring
- ๐งช AntiโFactor Xa Levels (not routine)
- Severe renal impairment.
- Extreme body weight (<40 kg or >150 kg).
- Pregnancy (some protocols).
- Unexpected bleeding or thrombosis.
- ๐ฉธ Platelet Count
- Baseline and periodic checks.
- Drop >50% โ suspect HIT.
- ๐งช Renal function (U&Es) before and during therapy.
๐ Common Formulations (UK)
- Enoxaparin
- Tinzaparin
- Dalteparin
- Fondaparinux (synthetic Xa inhibitor; LMWH-like use)
โ ๏ธ Formulations are not interchangeable on a unit-for-unit basis.
โ ๏ธ Side Effects
- ๐ฉธ Bleeding
- Most important complication.
- Only partially reversible.
- ๐งช Hyperkalaemia
- Due to aldosterone suppression.
- More likely with prolonged use.
- ๐ Thrombocytopenia (HIT)
- Immune-mediated.
- Paradoxical thrombosis.
- Stop all heparins immediately.
- ๐ฆด Osteoporosis
- With long-term use (>20 weeks).
- ๐ Injection-site reactions
๐ฉบ Practical Prescribing Tips
- ๐ Always calculate dose using actual body weight.
- ๐ซ Check eGFR before prescribing.
- ๐ Inject into abdominal wall; rotate sites.
- ๐ซ Avoid IM injections during therapy.
- ๐ Document indication and duration.
- ๐ Review daily in inpatients.
๐ก Safety Pearl: Any new thrombosis + falling platelets on LMWH = HIT until proven otherwise.